Deposition of advanced glycation end products (AGE) and expression of the receptor for AGE in cardiovascular tissue of the diabetic rat

International Journal of Experimental Pathology

Volumn 79, Issue 4, 1998, Pages 207-222

  Sun, Mei ^a   Yokoyama, Muinehiro ^a   Ishiwata, Toshiyuki ^a   Asano, Goro ^a  

^a NIPPON MEDICAL SCHOOL   (Japan)

Author keywords

Advanced glycation end products; Diabetic angiopathy; Rats; Receptor for advanced glycation end products; Streptozotocin

Indexed keywords

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; AORTA; ARTICLE; ATHEROSCLEROSIS; CONTROLLED STUDY; DIABETES MELLITUS; DIABETIC ANGIOPATHY; ELECTRON MICROSCOPY; IMMUNOHISTOCHEMISTRY; MALE; NONHUMAN; PRIORITY JOURNAL; PROTEIN GLYCOSYLATION; RAT; STREPTOZOCIN DIABETES;

ANIMALS; AORTA; DIABETES MELLITUS, EXPERIMENTAL; DIABETIC ANGIOPATHIES; ENDOTHELIUM, VASCULAR; GLYCOSYLATION END PRODUCTS, ADVANCED; HUMANS; IMMUNOENZYME TECHNIQUES; IN SITU HYBRIDIZATION; MALE; MEMBRANE PROTEINS; MICROSCOPY, ELECTRON; MUSCLE, SMOOTH, VASCULAR; MYOCARDIUM; POLYMERASE CHAIN REACTION; RATS; RATS, WISTAR; RECEPTORS, IMMUNOLOGIC; TIME FACTORS;

EID: 0031660675     PISSN: 09599673     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (41)

1. ALIPUI C., RAMOS K. & TENNER T.E. JR. (1993) Alterations of rabbit aortic smooth muscle cell proliferation in diabetes mellitus. Cardiovas. Res. 27, 1229-1232.
2. ANDREASSEN T.T., OXLUND H. & DANIELSEN C.C. (1988) The influence of nonenzymatic glycosylation and formation of fluorescent reaction products on the mechanical properties of rat tail tendon. Connect. Tissue Res. 17, 1-9.
3. ARAKI N., HIGASHI T., MORI T., SHIBAYAMA R., KAWABE Y., KODAMA T., TAKAHASHI K., SCIHIRI M. & HORIUCHI S. (1995) Macrophage scavenger receptor mediates the endocytic uptake and degradation of advanced glycation end products of the Maillard reaction. Eur. J. Biochem.. 230, 408-415.
4. BORNFELDT K.E., ARNQVIST H.J. & CAPRON L. (1992) In vivo proliferation of rat vascular smooth muscle in relation to diabetes mellitus insulin-like growth factor I and insulin. Diabetologica 35, 104-108.
5. BRETT J., SCHMIT A.M., ZOU Y.S., YAN S.D., WEIDMAN E., PINSKY D., NEEPER M., PRZYSIECKI M., SHAW A., MIGHELI A. & STERN D. (1993) Tissue distribution of the receptor for advanced glycation end products (RAGE): expression in smooth muscle, cardiac myocyte, and neural tissue in addition to the vasculature. Am. J. Pathol. 143, 1699-1712.
6. BROWNLEE M. (1995) Advanced protein glycosylation in diabetes and aging. Annu. Rev. Med. 46, 223-234.
7. CHAPPEY O., DOSQUET C., WAUTIER M.P. & WAUTIER J.L. (1997) Advanced glycation end products, oxidant stress and vascular lesions. Eur. J. Clin. Invest. 27, 97-108.
8. CHOMCZYNSKI P. & SACCHI N. (1987) Single-step method of RNA isolation by acid guanidinium thiocyanata-phenol.-chloroform extraction. Anal Biochem.. 162, 156-159.
9. ESPOSTIO C., GERLACH H., STERN D. & VLASSARA H. (1989) Endothelial receptor-mediated binding of glucose-modified albumin is associated with increased monolayer permeability and modulation of cell surface coagulant properties. J. Exp. Med. 170, 1387-1407.
10. FORT P., PIECHACZYK M., EL SABROUTY S., DANI C. & JEANTEUR P. (1985) Various rat adult tissues express only one major mRNA species from the glyceraldehyde-3-phosphate-dehydrogenase multigenic family. Nucl. Acids. Res. 13, 1431-1144.
11. GELISGEN R., SEVEN A.M., ERENSOY N., CANDAN G., YILMAZER S. & HATEMI H. (1993) Sorbitol. content and ultrastructure of the aortic tissues of streptozotocin diabetic rats: relation to plasma glucose, glycated hemoglobin and blood sorbitol. Biochem.. Soc. Transacti. 21, 286S.
12. HAUSDENCHILD C.C., SICKLE W.V. & CHOBANIAN A.V. (1981) Responce of the aorta of the obese Zucker rat to injury. Arteriosclerosis 1, 186-191.
13. HIGASHI T., SANO H., SAISHOJI T., IKEDA K., JINNOUCHI Y., KANZAKI T., MORISAKI N., RAUVARA H., SHICHRI M. & HORIUCHI S. (1997) The receptor for advanced glycation end products mediates the chemotaxis of rabbitt smooth muscle cells. Diabetes 46, 463-472.
14. ε-(carboxymethyl) lysine protein adduct is a major immunological epitope in proteins modified with advanced glycation end products of the maillard reaction. Biochemistry 35, 8075-8083.
15. JAFFE E.A., NACHMAN R.L., BECKER C.G. & MINICK C.R. (1973) Culture of human endothelial cell, derived from umbilical veins. J. Clin. Invest. 52, 2745-2756.
16. JARCIA M.J., MCNAMARA P.M. & JORDAN T. (1974) Morbidity and mortality in diabetes in Framingham population. Diabetes 23, 105-111.
17. KERSTEIN M., BRETT J., RADOFF S., OGAWA S., STERN D. & VLASSARA H. (1990) Advanced glycosylation induces transendothelial human monocytes chemotaxis and secretion of platelet-derived growth factor: role in vascular disease of diabetes and aging. Proc. Natl. Acad. Sci. USA. 87, 9010-9014.
18. KERSTEIN M., ASTON C., HINTZ R. & VLASSARA H. (1992) Receptor specific induction of insulin-like growth factor I in human monocytes by advanced glycosylation end product-modified proteins. J. Clin. Invest. 90, 439-446.
19. LAEMMLI U.K. (1970) Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 227, 680-685.
20. MENG J., SAKATA S., TAKEBAYASHI S., ASANO T., FUTATA T., ARAKI N. & HORIUCHI S. (1996) Advanced glycation end products of maillard reaction in aortic pepsin-insoluble and pepsin-soluble collagen from diabetic rats. Diabetes 45, 1037-1043.
21. NEEPER M., SCHMIT A.M., BRETT J., YAN S.D., WANG F., PAN Y.C.E., ELLISON K., STERN D. & SHAW A. (1992) Cloning and expression of a cell surface receptor for advanced glycation end products of protein. J. Biol. Chem. 267, 14998-15004.
22. NJOROGE F.G., SAYRE L.M. & MONNIER P. (1987) Detection of d-glucose derived pyrrole compounds during Maillard reaction under physiological conditions. Carbohyd. Res. 167, 211-220.
23. OKIKAWA S., HAYASAKA K., HASHIZUME E., KOTAKE H., MIDORIKAWA H., SEKIKAWA A., KIKUCHI A. & TOYOTA T. (1996) Human arterial smooth muscle cell proliferation in diabetes. Diabetes 45, S114-S116.
24. PALINSKI W., KOSCHINSKY T., BUTLER S.W., MILLER E., VLASSARA H., CERAMI A. & WEITZTUM J.L. (1995) Immunological evidence for the presence of advanced glycosylation end products in atherosclerotic lesions of euglycemic rabbits. Arterioscler. Throm. 15, 571-582.
25. PYORALA K., LAAKSO M. & UUSITUPA M. (1987) Diabetes and atherosclerosis: an epidemiologic view. Diabetes Metab. 3, 463-524.
26. RITTHALER U., DENG Y., ZHANG Y., GRETEN J., ABEL M., SIDO B., ALLENBERG J., OTTO G., ROTH H. & BIERHAUS A. (1995) Expression of receptors for advanced glycation end products in peripheral occlusive vascular disease. Am. J. Pathol. 146, 688-694.
27. SAKATA N., MENG J., JIMI S. & TAKEBAYASHI S. (1995) Nonenzymztic glycation and extractability of collagen in human atherosclerotic plaques. Atherosclerosis 116, 63-75.
28. SCHMIT A.M., VIANNA M., GERLACH M., BRETT J., RYAN J., KAO J., ESPOSITO C., HEGARTY H., HURLEY W., CLAUSS M. et al. (1992) Isolation and caracterization of binding proteins for advanced glycation end products from lung tissue which are present on the endothelial cell surface. J. Biol. Chem. 267, 14987-14997.
29. SCHMIT A.M., YAN S.D., BRETT J., MOPA R., NOWYGRAD R. & STERN D. (1993) Regulation of human mononuclear phagocyte migration by cell surface-binding proteins for advanced glycation endproducts. J. Clin. Invest. 91, 2155-2168.
30. SCHMIT A.M., HASU M., POPOV D., ZHANG J.H., YAN S.D., BRETT J., CAO R., KUWABARA K., COSTACHE G., SIMIONESCU N., SIMIONESCU M. & STERN D. (1994a) The receptor for advanced glycation endproducts (AGEs) has a central role in vessel wall interaction and gene activation in response to AGEs in the intravascular space. Proc. Natl. Acad. Sci. USA. 91, 8807-8811.
31. SCHMIT A.M., HORI O., BRETT J., YAN S.D., WAUTIER J.L. & STERN D. (1994b) Cellular receptors for advanced glycation endproducts. Arterioscl. Thromb. 14, 1521-1528.
32. SCHMIT A.M., HORI O., CHEN J.X., LI F., CRANDALL J., ZHANG J., CAO R., YAN S.D., BRETT J. & STERN D. (1995) Advanced glycation endoproducts interacting with their endothelial receptor induce expression of vascular cell adhesion molecle-1 (VCAM-1) in cultured human endothelial cells in mice. J. Clin. Invest. 96, 1395-1403.
33. SMITH P.R., SOMANI H.H., THORNALLEY P.J., BENN J. & SONKSEN P.H. (1993) Evidence against the formation of 2-amino-6-(2-formyl-5-hydroxymethyl-pyrrol.-yl) -hexanoic acid (pyrraline) as an early stage product or advanced glycation end products in non-enzymic protein glycation. Clin. Sci. 84, 87-93.
34. TEZUKA M., KOYAMA N., MORISAKI N., SAITO Y., YOSHIDA S., ARAKI N. & HORIUCHI S. (1993) Angiogenic effects of advanced glycosylation end products of Maillard reaction on cultured human umbilical cord vein endothelial cells. Biochem.. Biophys. Res. Commun. 193, 674-680.
35. TSO J.Y., SUN X., KAO T., REECE K.S. & WU R. (1985) Isolation and characterization of rat and human glyceraldehyde-3-phosphate dehydrogenase cDNAs: genomic complexity and molecular evolution of the gene. Nucl. Acids. Res. 13, 2485-2502.
36. VLASSARA H. (1994) Recent progress on the biologic and clinical significance of advanced glycosylation end products. J. Lab. Clin. Med. 124, 19-29.
37. VLASSARA H., BROWNLEE M., MANOGUE K.R., DINARELLO C.A. & PASSAGIAN A. (1988) Cachectin/TNF and IL-1 induced by glucose modified proteins: role in normal tissue remodeling. Science 240, 1546-1548.
38. VLASSARA H., LI Y.M., IMANI F., WOJCIECHOWICZ D., YANG Z., LIU F.-T. & CERAMI A. (1996) Identification of galectin-3 as a high affinity binding protein for advanced glycation end products (AGEs): a new member of the AGE-receptor complex. Mol. Med. 1, 634-646.
39. VLASSARA H., MOLDOWER L. & CHAN B. (1989) Macrophage/ monocyte receptor for nonenzymatic glycosylated protein is upregulated by cachectin/tumor necrosis factor. J. Clin. Invest. 84, 1813-1820.
40. WARLEY A., POWELL J.M. & SKEPPER J.N. (1995) Capillary surface area is rediced and tissue thickness from capillaries to myocytes is increased in the left ventricle of streptozotocin-diabetic rats. Diabetologia 38, 413-421.
41. WAUTIER J.L., ZOUKOURIAN C., CHAPPEY O., WAUTIER M.P., GUILLAUSSEAU P.J., CAO R., HORI O., STERN D. & SCHMIT A.M. (1996) Receptor-mediated endothelial cell dysfunction in diabetic vasculopathy. J. Clin. Invest. 97, 238-243.